logo

For the Inventor, By the Inventor

Clark, NJ, United States of America

Mu T Wu

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 175(Granted Patents)


Company Filing History:

goldMedal12 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1977-1999

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5965565 - Piperidines promote release of growth hormone (1999-10-12),
2. 5804578 - Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of (1998-09-08),
3. 5348955 - N,N-diacylpiperazines (1994-09-20),
4. 5344830 - N,N-diacylpiperazine tachykinin antagonists (1994-09-06),
5. 5292726 - N,N-diacylpiperazines (1994-03-08),
6. 5110799 - Antiherpetic agents (1992-05-05),
7. 4871739 - Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic (1989-10-03),
8. 4602002 - N-carboxymethyl substituted lysyl and .alpha.-(.epsilon.-aminoalkyl) (1986-07-22),
9. 4555503 - N.sup.2 -(Substituted)carboxymethyl-N.sup.6 -(substituted)-lysyl-and (1985-11-26),
10. 4555502 - Aminoacyl-containing dipeptide derivatives useful as antihypertensives (1985-11-26),
11. 4512979 - Dipeptides containing thialysine and related amino acids as (1985-04-23),
12. 4046753 - Substituted 2-phenylhydrazino and 2-phenylazo thiazolines (1977-09-06),

Title: Innovations of Mu T Wu in Growth Hormone Release

Introduction

Mu T Wu is a notable inventor based in Clark, NJ (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 12 patents, showcasing his innovative approach to enhancing growth hormone release in both humans and animals.

Latest Patents

One of his latest patents focuses on piperidines that promote the release of growth hormone. The invention is directed to specific piperidines, pyrrolidines, and hexahydro-1H-azepines, which are designed to improve growth hormone secretion. This property is particularly beneficial for promoting the growth of food animals, thereby enhancing the efficiency of edible meat production. Additionally, it addresses medical conditions in humans characterized by a deficiency in growth hormone, such as short stature in children. The growth hormone-releasing compositions containing these compounds serve as a significant advancement in medical treatments.

Career Highlights

Mu T Wu is currently associated with Merck & Company, Inc., where he continues to innovate in the pharmaceutical sector. His work has had a profound impact on the development of therapies aimed at improving growth hormone levels, which is crucial for various physiological conditions.

Collaborations

Throughout his career, Mu T Wu has collaborated with esteemed colleagues, including Arthur A Patchett and William J Greenlee. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Mu T Wu's innovative work in promoting growth hormone release has significant implications for both agriculture and medicine. His contributions continue to shape the landscape of pharmaceutical advancements, making a lasting impact on health and nutrition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…